Literature DB >> 18796505

'Restricting choices and limiting independence': social and economic impact of multiple sclerosis upon households by level of disability.

G Green1, J Todd.   

Abstract

OBJECTIVE: To examine the relationship between the social and economic impact of multiple sclerosis (MS) and levels of MS-related disability upon households in the following domains: household composition, housing modification, employment, standard of living, children, intimate and close relationships, and social life.
METHODS: A national sample of people with MS (pwMS) (n = 920), consisting of members of the MS Society and those accessing the MS Society website, completed a cross-sectional survey to generate quantitative and qualitative data.
RESULTS: Over three-quarters of the sample reported that MS had impacted on at least some areas of daily life. The reported impact increased significantly in a linear fashion in each domain with increasing disability, as measured by an activities of daily living index, although there was a discernible 'levelling off' in terms of impact in some domains among those at the higher levels of disability and dependency. Analysis of the qualitative data suggests that this impact can be conceptualized as a gradual process of 'restricting choices' and 'limiting independence' for both pwMS and their households. DISCUSSION: MS restricts social and economic opportunities for pwMS and those who they live with. These findings extend the literature to households to illustrate the impact of MS not only on pwMS but also on their partners, children and other family members.

Entities:  

Mesh:

Year:  2008        PMID: 18796505     DOI: 10.1177/1742395307087457

Source DB:  PubMed          Journal:  Chronic Illn        ISSN: 1742-3953


  9 in total

1.  What explains functioning from the perspective of people with multiple sclerosis?

Authors:  Andrea Conrad; Michaela Coenen; Jürg Kesselring; Alarcos Cieza
Journal:  J Neurol       Date:  2014-09-11       Impact factor: 4.849

2.  What are the support needs of men with multiple sclerosis, and are they being met?

Authors:  Dominic Upton; Charlotte Taylor
Journal:  Int J MS Care       Date:  2015 Jan-Feb

3.  Sex differences in predictors of illness intrusiveness in persons with multiple sclerosis.

Authors:  Lindsay O Neto; Elizabeth S Gromisch; Jessica Sloan; Tuula Tyry; Frederick W Foley
Journal:  Qual Life Res       Date:  2018-10-17       Impact factor: 4.147

4.  Identifying Barriers to and Facilitators of Health Service Access Encountered by Individuals with Multiple Sclerosis.

Authors:  Chantel D Mayo; Negar Farzam-Kia; Setareh Ghahari
Journal:  Int J MS Care       Date:  2021-02-23

Review 5.  Cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: a systematic review and meta-analysis.

Authors:  Daniel Hind; Jack Cotter; Anna Thake; Mike Bradburn; Cindy Cooper; Claire Isaac; Allan House
Journal:  BMC Psychiatry       Date:  2014-01-09       Impact factor: 3.630

Review 6.  The Relational Impact of Multiple Sclerosis: An Integrative Review of the Literature Using a Cognitive Analytic Framework.

Authors:  Joanna Blundell Jones; Sue Walsh; Claire Isaac
Journal:  J Clin Psychol Med Settings       Date:  2017-12

Review 7.  Disability Outcome Measures in Phase III Clinical Trials in Multiple Sclerosis.

Authors:  Bernard M J Uitdehaag
Journal:  CNS Drugs       Date:  2018-06       Impact factor: 5.749

Review 8.  Disabled in Society - A Scoping Review on Persons Living with Multiple Sclerosis and Disability.

Authors:  Daniel Ståhl; Ylva Bjereld; Anna Dunér
Journal:  J Multidiscip Healthc       Date:  2022-02-24

9.  Comparison of the effectiveness of a tailored cognitive behavioural therapy with a supportive listening intervention for depression in those newly diagnosed with multiple sclerosis (the ACTION-MS trial): protocol of an assessor-blinded, active comparator, randomised controlled trial.

Authors:  Litza Kiropoulos; Trevor Kilpatrick; Tomas Kalincik; Leonid Churilov; Elizabeth McDonald; Tissa Wijeratne; Jennifer Threader; Vanja Rozenblat; Neil O’Brien-Simpson; Anneke Van Der Walt; Lisa Taylor
Journal:  Trials       Date:  2020-01-20       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.